Neurava
Neurava is a startup headquartered in Baltimore, United States, founded in 2022. It has raised at least $1.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Neurava has raised at least $1.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Neurava sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Baltimore
- CraniUS
- Elixirgen Therapeutics
- Impruvon
- Infinity Bio
- Irazu Oncology
- ManaT Bio
- Mohawk Games
- Pearl Diagnostics
- Porter Cares
- Postr Technologies
- SudShare
Related
- Innovation profile of Baltimore
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Neurava do?
Neurava is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Neurava raised?
At least $1.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Neurava based?
Neurava is headquartered in Baltimore, United States.
When was Neurava founded?
Neurava was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.